Effect of High-Dose Vitamin D3 in Smokers and Non-Smokers With and Without HIV

Stopped early · Phase 1

Conditions studied: HIV/AIDS, Vitamin D Deficiency, Smoker Lung

In brief

Supplementation with vitamin D improves HIV+ macrophages phagocytosis in vitro. There is evidence to suggest that administering vitamin D can in fact improve immune function in individuals. The study will evaluate the impact of high dose vitamin D in HIV+ smokers' and HIV- smokers' in vivo. The primary goal is to improve innate immune host response to infection in patients already at high risk by virtue of HIV and smoking status.

Key facts

Study ID
NCT03270709
Run by
Emory University
People needed
7
Starts
2018-04-11
Expected to finish
2018-10-15
Last updated by the study team
2021-04-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.